Abattis Announces Resignation of Directors
Vancouver, British Columbia--(Newsfile Corp. - March 9, 2019) - Abattis Bioceuticals Corp (CSE: ATT) (OTC Pink: ATTBF) (the "Company" or "Abattis") announces that, effective February 20, 2019 and March 6, 2019, both Wolfgang Richter and James Irving have respectively resigned as directors of the Company.The Company thanks both Mr. Richter and Mr. Irving for their service and wishes each all the best in their future endeavors.About Abattis Bioceuticals Corp.Abattis is positioned to be a leader...
2019-03-09 11:00 AM EST
Abattis Bioceuticals Announces Board Change
Vancouver, British Columbia--(Newsfile Corp. - October 19, 2018) - Abattis Bioceuticals Corp. (CSE: ATT) (OTC Pink: ATTBF) (the "Company" or "Abattis") is pleased to announce the additions of Kent McParland and Cedric Wilson to the Board of Directors (the "Board"). Mr. McParland and Mr. Wilson replace Cameron Paddock and Rene David who have left Abattis to concentrate on other ventures. Mr. McParland is a Chartered Professional Accountant experienced in multiple industries and geographical...
2018-10-19 9:26 PM EDT
Abattis Completes Acquisition of Remaining Minority Interest in Gabriola Green Farms
Vancouver, British Columbia--(Newsfile Corp. - April 30, 2018) - Abattis Bioceuticals Corp. (the "Company" or "Abattis") (CSE: ATT / OTC: ATTBF) is pleased to announce, further to its news release dated April 18, 2018, that it has completed its acquisition of the remaining 10% ownership interest (the "Interest") in its subsidiary, Gabriola Green Farms Inc. ("Gabriola"). Abattis acquired the Interest from CannaNUMUS Blockchain Inc. for $2.5 million. Gabriola is now a wholly-owned subsidiary of...
2018-04-30 6:26 PM EDT
Abattis Enters into Agreement to Acquire Remaining Minority Interest in Gabriola Green Farms
Vancouver, British Columbia--(Newsfile Corp. - April 18, 2018) - Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the "Company" or "Abattis") is pleased to announce that it has entered into a share purchase agreement to acquire (the "Acquisition") the remaining 10% ownership interest in its subsidiary, Gabriola Green Farms Inc. ("Gabriola")."We are very happy to now own a 100% interest in Gabriola and integrate it as a wholly-owned subsidiary of Abattis. We believe that Gabriola's...
2018-04-18 1:22 PM EDT
Abattis Announces Board Changes
Vancouver, British Columbia--(Newsfile Corp. - April 13, 2018) - Abattis Bioceuticals Corp. (the "Company" or "Abattis") (CSE: ATT) (OTCQB: ATTBF) is pleased to announce the addition of Cameron Paddock to the Board of Directors. Mr. Paddock will fill the vacancy left by the resignation of Dr. Will Panenka who is leaving the Company to concentrate on other ventures."We are very excited have Mr. Paddock join our Board. On behalf of the Company, I would like to thank Dr. Panenka for his...
2018-04-13 2:07 PM EDT
Abattis Provides Correction to March 13, 2018 News Release
Vancouver, British Columbia--(Newsfile Corp. - March 26, 2018) - Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the "Company" or "Abattis") announces a correction to its news release dated March 13, 2018 (the "Release"). In the Release, Canadian Artesian Ice Ltd. ("Canadian Artesian") was described as being the bottlers of Clearly Canadian products. However, the Company has since been advised that Canadian Artesian are not the bottlers of Clearly Canadian products. About Abattis...
2018-03-26 10:23 PM EDT
Abattis Comments on Recent Market Activity
Vancouver, British Columbia--(Newsfile Corp. - March 1, 2018) - Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the "Company" or "Abattis"), wishes to make the following statements regarding certain market activity surrounding the Company's common shares (the "Common Shares"). On February 27, 2018, the Company was notified by the OTC Markets about certain promotional activities in relation to the Common Shares, including certain newsletter emails. The Company engaged Awareness Marketing...
2018-03-01 8:02 PM EST
Abattis Announces Presence at 2018 Lift Cannabis Expo and Provides Corporate Updates
Vancouver, British Columbia--(Newsfile Corp. - January 12, 2018) - Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the "Company" or "Abattis") is pleased to announce that, along with Northern Vine Labs, it will be attending the Lift Cannabis Expo, Canada's largest and best-attended cannabis tradeshow, from January 12 to 14 at the Vancouver Convention Centre. This year's Lift Expo will feature nearly 200 exhibitors from across North America and will host talks by cannabis thought...
2018-01-12 9:20 PM EST
Abattis Successfully Closes $6.9 Million Private Placement and Announces New $8 Million Private Placement
Vancouver, British Columbia--(Newsfile Corp. - January 10, 2018) - Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the "Company" or "Abattis") is pleased to announce that, further to its news release dated January 4, 2018, it has successfully closed its non-brokered private placement of units (each, a "Unit") for gross proceeds of $6.9 million (the "Private Placement"). "Abattis has once again oversubscribed its private placement," said Rob Abenante, President and CEO of Abattis. "The...
2018-01-10 5:17 PM EST
Abattis Successfully Closes $6.7 Million Private Placement and Announces New $6 Million Private Placement
Vancouver, British Columbia--(Newsfile Corp. - January 4, 2018) - Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the "Company" or "Abattis") is pleased to announce that, further to its news releases dated December 15 and December 19, 2017, it has completed the second and final tranche of its non-brokered private placement of units (each, a "Unit") for gross proceeds of $6.7 million (the "Private Placement"). "The Company continues to see overwhelming demand for its private placements,"...
2018-01-04 8:41 PM EST
Abattis Announces Letter of Intent to Acquire Winston Resources
Vancouver, British Columbia--(Newsfile Corp. - December 22, 2017) - Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the "Company" or "Abattis") is pleased to announce that, effective today, it has entered into a non-binding letter of intent (the "LOI") with Winston Resources Inc. ("Winston Resources"), a reporting issuer listed on the Canadian Securities Exchange, which outlines the general terms and conditions of a proposed transaction (the "Proposed Transaction") that will result in...
2017-12-22 9:28 AM EST
Abattis Successfully Closes $4 Million of $6 Million Private Placement
Vancouver, British Columbia--(Newsfile Corp. - December 19, 2017) - Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the "Company" or "Abattis") is pleased to announce that, further to its news release dated December 15, 2017, it has completed the first tranche of its non-brokered private placement of units (each, a "Unit") for gross proceeds of up to $6 million (the "Private Placement")."The Company is very pleased by overwhelming demand for our private placement" said Rob Abenante,...
2017-12-19 8:34 PM EST
Abattis Announces Private Placement for Proceeds of up to $6 Million
Vancouver, British Columbia--(Newsfile Corp. - December 15, 2017) - Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the "Company" or "Abattis") is pleased to announce that it is undertaking a non-brokered private placement (the "Offering") gross proceeds to the Company of up to $6 million."After strong demand for our last capital raise, the Company is pleased to announce a second capital raise at a significant increase in valuation" stated Rob Abenante, President and CEO of Abattis....
2017-12-15 7:15 PM EST
Abattis Successfully Closes Private Placement
Vancouver, British Columbia--(Newsfile Corp. - December 12, 2017) - Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the "Company" or "Abattis") is pleased to announce it has successfully closed the previously announced non-brokered private placement for gross proceeds of up to $4,000,000 (the "Private Placement")"We are pleased by the confidence strategic investors have shown by this capital raise. Abattis will continue to work on organically growing our portfolio and searching for only...
2017-12-12 6:15 PM EST
Abattis Announces Private Placement for Proceeds of up to $4 Million
Vancouver, British Columbia--(Newsfile Corp. - October 19, 2017) - Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the "Company" or "Abattis") is pleased to announce that it is undertaking a non-brokered private placement (the "Offering"), by issuing an aggregate of up to 22,222,222 units at a price of $0.18 per unit (each a "Unit"), raising gross proceeds to the Company of up to $4 million. Each Unit consists of one common share (a "Common Share") and one Common Share purchase warrant...
2017-10-19 10:33 PM EDT
Abattis Announces Vergence Update
Vancouver, British Columbia--(Newsfile Corp. - August 15, 2017) - Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the "Company" or "Abattis") is pleased to provide an update on its wholly-owned subsidiary, Vergence Visionary Bioceuticals ("Vergence"), which is a nutraceutical marketing and brand specialist firm focused on bringing innovative health products to market.New Brand PartnershipsVergence has recently signed an agreement to distribute Jonny Hetherington Essentials, a line of...
2017-08-15 11:19 AM EDT
Abattis Adds New Product Line to Wholly-Owned Subsidiary Vergence Naturals Distribution Portfolio
Vancouver, British Columbia--(Newsfile Corp. - August 11, 2017) - Abattis Bioceuticals Corp. (CSE: ATT) (OTC: ATTBF) (the "Company" or "Abattis") is pleased to announce it has reached a deal with Jonny Hetherington Essentials for major distribution of their products throughout North America and potentially Asia, through its wholly-owned subsidiary, Vergence Visionary Bioceuticals ("Vergence" or "Vergence Naturals").The agreement with Jonny Hetherington Essentials, has the potential to bring...
2017-08-11 9:18 AM EDT
Abattis Files Amended and Restated Financial Statements For the Period Ended March 31, 2017
Vancouver, British Columbia--(Newsfile Corp. - August 9, 2017) - Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the "Company" or "Abattis") announces that, as a result of a review by the British Columbia Securities Commission, we are issuing the following press release to clarify our disclosure.The review identified certain discrepancies in our condensed consolidated financial statements for the three and six months ended March 31, 2017 (the "Financial Statements"). As a result, we...
2017-08-09 9:02 PM EDT
Abattis Expands and Strengthens Its Asian Distribution Sales Channels
Vancouver, British Columbia--(Newsfile Corp. - July 25, 2017) - Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the "Company" or "Abattis") is pleased to announce the appointment of Mr. Wei Ma to oversee export and business development in Asia, in an effort to further expand and strengthen the Company's Asian distribution channels.Mr. Ma has over 15 years of experience in international trade, with a focus on importing and exporting in Asia. His deep understanding and knowledge stems...
2017-07-25 8:45 AM EDT
Abattis Obtains DTC Eligibility
Vancouver, British Columbia--(Newsfile Corp. - July 17, 2017) - Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the "Company" or "Abattis") is pleased to announce that it has obtained Depository Trust Company ("DTC") eligibility in the United States ("US"). The DTC is a stock depository and facilitates electronic trading in the US. When shares are DTC eligible, trades are completed electronically in a more cost effective and timely method for settlement. Shares that are DTC eligible...
2017-07-17 8:15 AM EDT